Although the 1996 NCI-WG guidelines have been widely used and are accepted for response assessment of Chronic Lymphocytic Leukemia (CLL), the intent of the more recent 2008 IWCLL guidelines was to replace the earlier guidelines as the preferred criteria to be used for future clinical trials. Refer to the 2008 IWCLL guidelines for current recommendations on the assessment of CLL in clinical trials.

Key Offerings

Key Materials

Key Offerings

Key Materials

SHOW MORE

SHOW MORE

Make 1996 NCI-WG CLL part of your solution

The correct interpretation and application of published assessment criteria is essential to providing reliable response outcomes that will accurately reflect efficacy and will stand up to scrutiny by regulators. Let PAREXEL guide you to the right response assessment.

Criteria Experience

Products and Services

The correct interpretation and application of published assessment criteria is essential to providing reliable response outcomes that will accurately reflect efficacy and will stand up to scrutiny by regulators. Let PAREXEL guide you to the right response assessment.